Prosecution Insights
Last updated: November 04, 2026

Ironshore Pharmaceuticals & Development Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Ironshore Pharmaceuticals & Development Inc. maintains a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is currently 1 pending office action recorded for this portfolio. This indicates a concentrated prosecution phase, where the company is focusing its resources on a specific pharmaceutical or biotechnological advancement.

The portfolio's active matters are handled by 1 distinct examiner and 1 distinct art unit. This suggests that the technology being patented is highly specialized, requiring review by a specific examination group. The absence of multiple examiners or units means that the prosecution strategy is not fragmented across different parts of the patent office.

YOUNG, MICAH PAUL is the busiest examiner for this portfolio, with 1 busiest examiner pending office action. Because the total number of pending office actions is 1, this examiner is responsible for all current pending matters. The focus on 1 distinct art unit and 1 distinct examiner ensures that the company's current patent prosecution is centralized and consistent.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
YOUNG, MICAH PAUL 1 55.1% +30.0%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18057819 METHYLPHENIDATE COMPOSITIONS FOR TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER YOUNG, MICAH PAUL —

Top Art Units

Art UnitApps
1618 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18057819 METHYLPHENIDATE COMPOSITIONS FOR TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER YOUNG, MICAH PAUL 1618 DP Final Rejection — Pending Nov 22, 2022

Managing Ironshore Pharmaceuticals & Development Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Ironshore Pharmaceuticals & Development Inc. have?

Ironshore Pharmaceuticals & Development Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Ironshore Pharmaceuticals & Development Inc. applications?

Micah Paul Young has the most, with 1 of Ironshore Pharmaceuticals & Development Inc.'s pending office actions.

What technology area are Ironshore Pharmaceuticals & Development Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month